General Healthcare - European Medical Journal

This site is intended for healthcare professionals

Continue

General Healthcare

Filter
EMJ
16 Nov 2015

Drinking the EU Economy Dry: Experts Call for Action on the Crippling Socio-Economic Costs of Alcohol

November 12, 2015: Europe is the heaviest drinking region of the world, with consumption levels in some countries approximately twice the global average.
EMJ
11 Nov 2015

RapidPlan Knowledge-Based Radiotherapy Treatment Planning

Earlier this year, a 76-year-old man with prostate cancer became the first radiotherapy patient in the world whose treatment was planned using…
EMJ
26 Oct 2015

Sniffing and Gasping Can Prevent Fainting

Vienna, Austria – 17 October 2015: Sniffing and gasping can prevent fainting, reveals research presented today at Acute Cardiovascular Care 2015…
EMJ
1 Oct 2015

Norgine Completes Agreement With Aspen For Its Southern African Operations And Product Rights

London. 30 September 2015, 14:00 BST. Norgine B.V. today announced that it has completed its agreement with Pharmacare Limited, a wholly owned subsidiary…
EMJ
1 Oct 2015

Lifestyle Intervention Programme : Multidisciplinary Approach Increased Compliance by 450%

The Specialist Health Centre, an organisation working alongside the Essex primary and secondary care trusts, has recently responded to the demand for…
EMJ
15 Sep 2015

NITID (Optical Coherence Tomography and Digital Dermatoscope Handheld Device) – CE Mark Approval Received

Madrid, September 10, 2015. DermaLumics, a recently founded spin-off of optical tomography systems developer MedLumics, announces that NITID…
EMJ
27 Aug 2015

Janssen Submits European Extension Marketing Authorisation Application for Paliperidone Palmitate Once-Every-Three-Months Formulation

BEERSE, Belgium, 21st August 2015 – Janssen-Cilag International NV (Janssen) today announced the submission of an Extension Marketing Authorisation…
EMJ
21 Aug 2015

European Medicines Agency Validates Gilead’s Marketing Application for Single Tablet Regimen Containing Rilpivirine, Emtricitabine and Tenofovir Alafenamide (R/F/TAF) for HIV Treatment

Foster City, CA, August 20, 2015 – Gilead Sciences, Inc. (NASDAQ: GILD) today announced that the company’s Marketing Authorization Application (MAA)…
We’ve noticed you’re accessing
from North/South America.